GSR
MOLECULAR TARGETglutathione-disulfide reductase
GSR (glutathione-disulfide reductase) is targeted by 6 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GSR
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | nifedipine | 5.34 | 208 |
| 2 | methylene blue anhydrous | 3.93 | 50 |
| 3 | molibresib | 3.81 | 44 |
| 4 | Methylene Blue | 0.69 | 1 |
| 5 | Carmustine | 0.69 | 1 |
| 6 | Meloxicam | 0.69 | 1 |
About GSR as a Drug Target
GSR (glutathione-disulfide reductase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 6 compounds with documented GSR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GSR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.